Xtant Medical Holdings, Inc. (XTNT) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Cash Runway Insiders Research

Home›Companies›Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings, Inc.

XTNT

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 0.0% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

OrbiMed Advisors

Position Trend

May 15, 2025

$34.4M

1 fund

Aug 14, 2025

0 funds

Nov 14, 2025

0 funds

Feb 17, 2026

0 funds

-100% total institutional value over 4 quarters

Short Interest

Short Shares

23K

Change

-17.6%

Days to Cover

0.3

% of Float

0.0%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/AOrbiMed Advisors0.0%Apr 14, 2025

SC 13D/AOrbiMed Advisors52.7%Sep 10, 2024

SC 13D/AOrbiMed Advisors56.7%Aug 3, 2023

SC 13D/AOrbiMed Advisors67.1%May 5, 2023

SC 13D/AOrbiMed Advisors67.9%Aug 30, 2022

SC 13D/AOrbiMed Advisors84.0%Apr 9, 2021

SC 13D/AOrbiMed Advisors93.6%Feb 26, 2021

SC 13D/AOrbiMed Advisors94.8%Oct 5, 2020

SC 13D/AOrbiMed Advisors77.7%May 20, 2020

SC 13D/AOrbiMed Advisors74.6%Apr 4, 2019

SC 13D/AOrbiMed Advisors72.6%Sep 19, 2018

SC 13D/AOrbiMed Advisors70.4%Feb 15, 2018

SC 13D/AOrbiMed Advisors13.8%Jan 17, 2018

SC 13DOrbiMed Advisors9.9%May 30, 2017

SC 13G/AOrbiMed Advisors10.0%Feb 13, 2017

Position Details

OrbiMed AdvisorsEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

3 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

APLS1 fund ARGX1 fund CTMX1 fund ACET1 fund PTCT1 fund ADCT1 fund MLYS1 fund PRAX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer